To determine if the addition of Armodafinil will help reduce patient's reported fatigue associated with chemotherapy and radiation therapy.
Must have completed radiation therapy treatments greater than 21 days and less than or equal to 24 months before enrollment. Must meet a certain level of fagitue. Must be willing to complete questionnaires.
Currently not taking any medication of ADHD, severe anxiety disorder, schizophrenia or substance abuse.